BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33436059)

  • 1. An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease.
    Yu Q; Mai Y; Ruan Y; Luo Y; Zhao L; Fang W; Cao Z; Li Y; Liao W; Xiao S; Mok VCT; Shi L; Liu J; ;
    Alzheimers Res Ther; 2021 Jan; 13(1):23. PubMed ID: 33436059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning based hierarchical classification of frontotemporal dementia and Alzheimer's disease.
    Kim JP; Kim J; Park YH; Park SB; Lee JS; Yoo S; Kim EJ; Kim HJ; Na DL; Brown JA; Lockhart SN; Seo SW; Seong JK
    Neuroimage Clin; 2019; 23():101811. PubMed ID: 30981204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    Mai Y; Yu Q; Zhu F; Luo Y; Liao W; Zhao L; Xu C; Fang W; Ruan Y; Cao Z; Lei M; Au L; Mok VCT; Shi L; Liu J
    J Alzheimers Dis; 2021; 79(3):1023-1032. PubMed ID: 33459705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric computer-aided differential diagnosis of Alzheimer's disease and frontotemporal dementia using structural and advanced MRI.
    Bron EE; Smits M; Papma JM; Steketee RME; Meijboom R; de Groot M; van Swieten JC; Niessen WJ; Klein S
    Eur Radiol; 2017 Aug; 27(8):3372-3382. PubMed ID: 27986990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
    Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
    J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
    Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
    Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer's Disease and Mild Cognitive Impairment.
    Marterstock DC; Knott MFX; Hoelter P; Lang S; Oberstein T; Kornhuber J; Doerfler A; Schmidt MA
    Tomography; 2022 Jan; 8(1):229-244. PubMed ID: 35076603
    [No Abstract]   [Full Text] [Related]  

  • 10. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    Nicastro N; Malpetti M; Cope TE; Bevan-Jones WR; Mak E; Passamonti L; Rowe JB; O'Brien JT
    J Alzheimers Dis; 2020; 76(1):331-340. PubMed ID: 32444550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
    Carnemolla SE; Kumfor F; Liang CT; Foxe D; Ahmed RM; Piguet O
    J Alzheimers Dis; 2022; 89(1):51-66. PubMed ID: 35848020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.
    Krueger CE; Dean DL; Rosen HJ; Halabi C; Weiner M; Miller BL; Kramer JH
    Alzheimer Dis Assoc Disord; 2010; 24(1):43-8. PubMed ID: 19571735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    Huey ED; Lee S; Cheran G; Grafman J; Devanand DP;
    J Alzheimers Dis; 2017; 55(2):551-558. PubMed ID: 27802220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.
    Elahi FM; Marx G; Cobigo Y; Staffaroni AM; Kornak J; Tosun D; Boxer AL; Kramer JH; Miller BL; Rosen HJ
    Neuroimage Clin; 2017; 16():595-603. PubMed ID: 28975068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.
    Bocti C; Rockel C; Roy P; Gao F; Black SE
    Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
    Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
    Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia.
    Huang M; Landin-Romero R; Matis S; Dalton MA; Piguet O
    J Neurol; 2024 May; 271(5):2509-2520. PubMed ID: 38265470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia.
    Landin-Romero R; Kumfor F; Leyton CE; Irish M; Hodges JR; Piguet O
    Neuroimage; 2017 May; 151():72-80. PubMed ID: 27012504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.